About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Preventive Risk Outreach And Cascade Testing | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNANCT07478237

The Preventive Risk Outreach And Cascade Testing

The goal of this clinical trial is to learn whether a new online program developed by the research team is able to help families learn about family cancer risk and how to reduce this risk, as well as ...

Lead sponsor: Stanford University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Sonia Rios-Ventura

CONTACT

6507258762 proactprogram@stanford.edu

Sponsors

Lead Sponsor

Stanford University

Collaborators

University of Michigan

The overarching goal of this study is to facilitate cascade genetic testing to reduce the burden of cancer in families with hereditary cancer syndromes (HCS). We will evaluate different versions of a point-of-care cascade genetic testing referral service for probands with recently detected pathogenic or likely pathogenic genetic variants.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Age ≥ 18 years old.
•2. Known to carry a pathogenic or likely pathogenic variant in a gene included in the 2024 current Color Health Cancer Panel Test.
•3. Have at least one (1) first- or second-degree relative who is living in the United States and has not yet had germline genetic testing.
•1. Age ≥ 18 years old.
•2. Resides in the United States.

Exclusion Criteria

•1\. Unable to read and write English or Spanish.
•1. Completed genetic testing by a clinician within the last 5 years that included the pathogenic or likely pathogenic variant.
•2. Not a first- or second-degree relative of the proband.

Related studies

Rare Tumors and Cancer Predisposition in Individuals and Families

NCT05350761 · Cancer, Hereditary Neoplasms, and more

RECRUITINGPhase 4

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

NCT06003153 · Genetic Predisposition, Metabolic Diseases, and more

EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer

NCT04141462 · Cancer, Genetic Predisposition

Healthy Volunteers Study

NCT06962059 · Ovarian Cancer, Genetic Predisposition to Disease

Precision Medicine in the Prostate Cancer Care Pathway

NCT04763317 · Prostate Cancer, Genetic Predisposition

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 17, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment400

Start dateJun 2026

Last updatedMar 17, 2026

Condition

Genetic Predisposition Family Members

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 17, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions